Search results
Results from the WOW.Com Content Network
Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. [12] [14] [15] [16] It is administered by slow intravenous ...
Keytruda slashed the risk of death by 21% over placebo in hepatocellular carcinoma patients in Asia who had previously received sorafenib. Merck's Keytruda also beat placebo at shrinking tumors ...
An excess of free fatty acids in liver cells plays a role in Nonalcoholic Fatty Liver Disease (NAFLD). In the liver, it is the type of fatty acid, not the quantity, that determines the extent of the lipotoxic effects. In hepatocytes, the ratio of monounsaturated fatty acids and saturated fatty acids leads to apoptosis and liver damage. There ...
If you are concerned about yourself or a loved one, call the Substance Abuse and Mental Health Services Administration's (SAMSA) confidential, free, 24-hour-a-day, 365-day-a-year helpline at 1-800 ...
In September 2020, Dailymotion partnered with Mi Video, the global video app developed by Xiaomi. [16] The partnership will help Mi Video to increase its engagement with its audience and continue its growth momentum. Access to Dailymotion's global and regional music, entertainment, sports and news catalogues will be provided to Mi Video users. [17]
To slow or maybe even reverse organ damage linked to aging, scientists must first figure out what goes wrong at the cellular level. Duke University researchers are gaining ground on that quest ...
Pyrrolizidine alkaloidosis can result in damage to the liver, kidneys, heart, brain, smooth muscles, lungs, DNA, lesions all over the body, and could be a potential cause of cancer. [ 1 ] [ 2 ] Pyrrolizidine alkaloidosis is known by many other names such as "Pictou Disease" in Canada [ 3 ] and "Winton Disease" in New Zealand. [ 4 ]
Let your provider know about any changes in your circumstances or if the side effects of semaglutide are bothering you. They can monitor your treatment plan and tell you if you need to stop taking ...